ijms-logo

Journal Browser

Journal Browser

Dietary Bioactive Components in Inflammatory Bowel Disease, 2nd Edition

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Bioactives and Nutraceuticals".

Deadline for manuscript submissions: 20 August 2025 | Viewed by 2479

Special Issue Editors


E-Mail Website
Guest Editor
Department of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy
Interests: inflammation; oxidative stress; berries and antioxidant
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Via Brecce Bianche 10, 60131 Ancona, Italy
Interests: fruits; breeding; diversity; traditional uses; ethnoveterinary; characterization of phytochemicals
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Inflammatory bowel disease (IBD) represents chronic debilitating inflammatory disorders that can affect different parts of the gastrointestinal tract and are commonly correlated to two main diseases: Crohn’s disease and ulcerative colitis. These inflammatory conditions can lead to the development of severe complications such as anemia, malnutrition, infection, and an increased risk of colon cancer, one of the most common cancers worldwide. Despite intense research efforts, the etiology of IBD is not well established, but it is reasonably hypothesized that the interactions of multiple factors, including environmental and genetic factors, intestinal microbiota, and immune response, are involved in IBD promotion. Considering that there is no cure for IBD and that the incidence of this disorder has shown an increasing trend over the last few decades, nutritional support plays an important role in alleviating IBD symptoms and promoting healing. For all these reasons, it is very important to emphasize the scientific rationale behind the benefits of incorporating phytochemicals and other dietary bioactive compounds mainly present in fruits and vegetables as a nutritional supplement for the prevention and treatment of IBD, considering their consolidated and widely investigated anti-inflammatory and anti-oxidative effects.

Thus, this Special Issue will investigate the recent advances in the study of the role exerted by dietary bioactive compounds against IBD, focusing attention on the cellular processes, the molecular mechanisms, and the involved pathways, in order to elucidate their possible beneficial health effects and to promote their efficacy in this disease management. Topics related to both original and reviewed articles are welcome. Papers only containing extraction data will not be accepted because the focus should be on the chemical composition of ingredients and, more specifically, on describing their mechanism of action in improving human nutrition.

Dr. Massimiliano Gasparrini
Dr. Luca Mazzoni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • IBD
  • dietary bioactive compounds
  • molecular mechanisms
  • health promotion
  • prevention
  • antioxidant
  • anti-inflammatory
  • nutritional support

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

25 pages, 2706 KiB  
Review
Polyphenol Intake in Elderly Patients: A Novel Approach to Counteract Colorectal Cancer Risk?
by Stefania Fumarola, Laura Cianfruglia, Monia Cecati, Cinzia Giammarchi, Salvatore Vaiasicca and Massimiliano Gasparrini
Int. J. Mol. Sci. 2025, 26(6), 2497; https://doi.org/10.3390/ijms26062497 - 11 Mar 2025
Viewed by 604
Abstract
Colorectal cancer (CRC) accounts for approximately 10% of all cancers worldwide with an incidence of approximately 60% in patients older than 70 years. In the elderly, the definition of a better therapeutic strategy depends on several factors including the patient’s frailty and comorbidity [...] Read more.
Colorectal cancer (CRC) accounts for approximately 10% of all cancers worldwide with an incidence of approximately 60% in patients older than 70 years. In the elderly, the definition of a better therapeutic strategy depends on several factors including the patient’s frailty and comorbidity status, life expectancy, and chemotherapy tolerance. In older patients, adverse drug reactions require a reduction in the dose of treatment, resulting in worse oncologic outcomes. In recent years, an increasing number of studies have focused on the potential effects of polyphenols on human health and their use in cancer therapy. In this comprehensive review, we searched the major databases and summarized experimental data of the most important polyphenols in the CRC chemoprevention, with a focus on the molecular mechanisms involved and the antitumor effects in the elderly population. In vitro and in vivo studies have shown that polyphenols exert chemopreventive activity by modulating cell signaling, resulting in the inhibition of cancer development or progression. However, the efficacy seen in experimental studies has not been confirmed in clinical trials, mainly due to their low bioavailability and non-toxic doses. Further research is needed to increase polyphenol bioavailability and reduce side effects in order to suggest their possible use to increase the efficacy of chemotherapeutic treatment. Full article
Show Figures

Figure 1

31 pages, 3467 KiB  
Review
Drosophila: An Important Model for Exploring the Pathways of Inflammatory Bowel Disease (IBD) in the Intestinal Tract
by Chuisheng Zeng, Fengying Liu, Yuhan Huang, Qianqian Liang, Xiaohong He, Lingzhi Li and Yongfang Xie
Int. J. Mol. Sci. 2024, 25(23), 12742; https://doi.org/10.3390/ijms252312742 - 27 Nov 2024
Cited by 1 | Viewed by 1207
Abstract
Inflammatory bowel disease (IBD) is a chronic and recurring lifelong condition, the exact etiology of which remains obscure. However, an increasing corpus of research underscores the pivotal role of cellular signaling pathways in both the instigation and management of intestinal inflammation. Drosophila, [...] Read more.
Inflammatory bowel disease (IBD) is a chronic and recurring lifelong condition, the exact etiology of which remains obscure. However, an increasing corpus of research underscores the pivotal role of cellular signaling pathways in both the instigation and management of intestinal inflammation. Drosophila, owing to its prodigious offspring, abbreviated life cycle, and the conservation of signaling pathways with mammals, among other advantages, has become a model organism for IBD research. This review will expound on the feasibility of utilizing Drosophila as an IBD model, comparing its intestinal architecture with that of mammals, its inflammatory responses, and signaling pathways. Furthermore, it will deliberate on the role of natural products across various biological models of IBD pathways, elucidating the viability of fruit flies as IBD models and the modus operandi of cellular signaling pathways in the context of IBD. Full article
Show Figures

Figure 1

Back to TopTop